about
sameAs
Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials?The Valley of Death in anticancer drug development: a reassessmentInadequate dissemination of phase I trials: a retrospective cohort studyDrug Discovery in Academia- the third way?The case for open-access chemical biology. A strategy for pre-competitive medicinal chemistry to promote drug discoveryAdvances in Nuclear Magnetic Resonance for Drug Discovery.The battle of Alzheimer's Disease - the beginning of the future Unleashing the potential of academic discoveries.Towards personalized agriculture: what chemical genomics can bring to plant biotechnologyNatural products and ion channel pharmacologyHigh-content screening data management for drug discovery in a small- to medium-size laboratory: results of a collaborative pilot study focused on user expectations as indicators of effectiveness.The future of molecular dynamics simulations in drug discovery.The current state of drug discovery and a potential role for NMR metabolomics.The Alabama Drug Discovery Alliance: a collaborative partnership to facilitate academic drug discovery.Alcohol and opioid dependence medications: prescription trends, overall and by physician specialtyMitigating risk in academic preclinical drug discovery.US academic drug discovery.Translational research in infectious disease: current paradigms and challenges ahead.Drug repurposing: far beyond new targets for old drugs.Drug absorption modeling as a tool to define the strategy in clinical formulation development.Orphan targets for reperfusion injury.The significance of non-human primates as preclinical models of human arthritic disease.Multitarget ligands and theranostics: sharpening the medicinal chemistry sword against prion diseases.Addressing the right targets in oncology: challenges and alternative approaches."Omics"-Informed Drug and Biomarker Discovery: Opportunities, Challenges and Future Perspectives.Emerging applications of metabolomics in drug discovery and precision medicine.The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta-analyses.Simulating the drug discovery pipeline: a Monte Carlo approach.Are the large pharmaceutical and biotechnology companies driving the discovery, research and development of targeted cancer therapies?Drug discovery paradigms: past, present, future - a centennial symposium of the American Society for Pharmacology and Experimental Therapeutics.Cell biology: a key driver of therapeutic innovation.Eminence or Evidence? The Volatility, Uncertainty, Complexity, and Ambiguity in Healthcare.Combination Drug Therapy for Pain following Chronic Spinal Cord Injury.Impact of high-throughput screening in biomedical research.Influence of molecular properties on oral bioavailability of lipophilic drugs - mapping of bulkiness and different measures of polarity.Orphan diseases: state of the drug discovery art."Collaborative innovation"--regaining the edge in drug discovery.Eyes on the prize: bringing individualized therapy from the bedside to clinical practice.Creativity in large pharmaceutical research organizations: unleash the hungry drug hunter.A virtual high-throughput screening approach to the discovery of novel inhibitors of the bacterial leucine transporter, LeuT.Understanding drug-likeness
P2860
Q24288917-E298BF9D-1A4C-4DE3-83D3-5E60CC065547Q26861274-D5507E27-F02D-422B-8496-C323550099D8Q28474828-5EAEFB36-0685-4B5E-A20D-0FA5C580FB5CQ28749049-E6836194-2EA8-46BE-82D7-67A03E05F246Q28751328-4FCDCBC7-A8F0-4515-9835-6E6B8E46223DQ30387229-974CF29B-B6AF-477D-8BEE-7973345DB494Q33620099-19723FC8-5A41-4FC4-8174-BD61BACA7CF9Q34054953-DCDD2873-E694-4A71-87FB-BE245107F507Q34128527-DE724E90-65E0-4105-837B-BE834E3D38F9Q34167197-8C0B347F-2FA2-4533-A293-EAB53E7E11E7Q34241696-5A9C20E1-D48B-4F3C-92BA-7403A6EC7781Q35072850-DBFDD8C8-8589-40DF-90BF-6FB46FBAB5D6Q35180535-6344BB03-B28F-4DAA-9692-8F651A51D5E3Q35195803-849379B3-CAFD-4129-A00D-78FF6F3A1399Q35591567-32913A5B-1617-4108-97D4-9ECF8F0970DEQ35702741-3438F725-BDE1-465D-A8FF-6C6916D58679Q35992621-7B1E0983-BCFD-4153-B402-C4C7EEC155F1Q36331528-DEF746CE-5FB4-4E8F-84D9-064986C1E077Q37254283-BFF99E0E-09C1-4AB3-A118-127D8F54FA5EQ37436743-B1A30E0E-7EE6-4485-94B8-B72FCF2741B4Q38088311-A0FF95DE-C5F5-47C9-91CB-F16CCA7B4800Q38234645-C8D09694-B89C-4C89-8CA4-7C754FFEF5A5Q38329647-5262F0A1-BB6C-4823-AF18-BD3E3501F6A2Q38752029-1458D86E-6B47-4B71-AA6E-528869956F37Q38769103-5A52891C-3C09-45BB-BC8D-93653B99D9AAQ38952676-CFBE1FF1-5D74-4625-BF68-5215F7FF3EACQ39513499-47431DDF-6EA2-4D30-81ED-D37FB749E084Q39675893-704E86AD-F8A0-436F-8E98-C97CB6177BB7Q40053591-A267F8DD-AEEC-49D0-8F07-66ECA5B2A778Q41265920-875C7B91-27ED-4A4D-B42C-B16E600AB54AQ42371169-42C8CDE0-99A7-4090-AA83-BD0494037A3CQ42548830-37D52139-8314-42F2-AEEB-43AEFFC0DE6EQ45352809-B41CF3CA-2ACE-4D04-AE3C-75D36810E3B0Q45371827-BFD8C738-36CE-4FC4-BC80-261ACC88D5BFQ45882722-B0F61D99-FF61-440C-9439-E86F4D69EB32Q46670214-4296C3A5-4F7F-4482-9350-E80C7F3E694BQ48326951-953F9C3A-0049-45BB-B023-7FA7246AAE7AQ50663633-E17C4BF0-5F08-4A1D-AB87-62F28A288D63Q52842709-A9D6D797-024D-4CE8-9D07-DC626C246F0BQ57016955-1766EC87-D88A-4C62-B91D-F96C1370B51F
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Drug discovery in jeopardy
@ast
Drug discovery in jeopardy
@en
Drug discovery in jeopardy
@en-gb
Drug discovery in jeopardy
@nl
type
label
Drug discovery in jeopardy
@ast
Drug discovery in jeopardy
@en
Drug discovery in jeopardy
@en-gb
Drug discovery in jeopardy
@nl
prefLabel
Drug discovery in jeopardy
@ast
Drug discovery in jeopardy
@en
Drug discovery in jeopardy
@en-gb
Drug discovery in jeopardy
@nl
P2860
P356
P1476
Drug discovery in jeopardy
@en
P2860
P304
P356
10.1172/JCI29999
P407
P577
2006-11-01T00:00:00Z